Clinical Software

L&R Ultrasonics manufactures ultrasonic cleaning systems and solutions for medical, dental, industrial, and specialty markets. The company specializes in instrument sterilization and disinfection equipment, including their flagship SweepZone® line of ultrasonic cleaners designed for high-volume dental and medical office instrument processing. Key product lines include the SweepZone 310R with digital timer (3.2-gallon capacity accepting 6 small or 3 large cassettes) and larger SweepZone 1000 systems. L&R also offers UltraDose® WaveCheck® ultrasonic test monitor strips—recognized as a Top 100 Product of 2021 by Dentistry Today—for validating ultrasonic cleaner performance. The company serves dental practices, medical facilities, hospitals, firearms maintenance, jewelry/watch repair, fire/EMS, and industrial sectors. L&R provides application-based cleaning solutions, ultrasonic cleaning chemistry, and specialty services including custom cleaning evaluations, private-label/OEM partnerships, and technical support. The company maintains ISO certifications and publishes technical resources including safety data sheets (SDS), application bulletins, and product literature. Founded in Kearny, New Jersey, L&R operates with a team of application chemists and engineers offering consultation and customized cleaning protocols.

Bruker Corporation is a global leader in high-performance scientific instruments and analytical solutions for life sciences research and diagnostics. The company manufactures a broad portfolio of analytical instruments including nuclear magnetic resonance (NMR) spectrometers, X-ray fluorescence (XRF) spectrometers, Fourier-transform infrared (FT-IR) and Raman spectrometers, electron paramagnetic resonance (EPR) systems, and advanced microscopy platforms. Bruker's diagnostic division offers the MALDI Biotyper® and IR Biotyper® systems for microbial identification, as well as the MyGenius PRO® molecular diagnostics system for sample-to-answer PCR-based infectious disease testing. The company also provides spatial biology platforms for multi-omics analysis (DNA, RNA, protein) and light-sheet microscopy systems such as the Papilio5D for 3D cell culture imaging. Bruker serves academia, biopharma, clinical diagnostics, and industrial markets globally. Products include handheld XRF analyzers (TITAN), bench-top vacuum FT-IR spectrometers (VERTEX NEO Ultra), nanomechanical testing systems (Hysitron PI Envision), and specialty analyzers for dairy and food quality control (MOVE-T). The company maintains significant R&D capabilities and offers comprehensive customer support services, consumables, accessories, and software through the Bruker Store. Bruker operates manufacturing and R&D facilities in Billerica, Massachusetts, and globally.

RemetricHealth is a remote patient monitoring (RPM) and chronic care management provider serving physician groups, hospitals, home health agencies, community health centers, and payers across the United States. The company delivers real-time biometric and compliance monitoring combined with clinical nursing services to assess patients remotely between office visits. Core offerings include FDA-cleared wireless biometric devices (primarily blood pressure monitors, glucose meters, and weight scales), a HIPAA-compliant web portal and mobile applications for both healthcare staff and patients, and clinical support services performed by RemetricHealth's nursing staff. The platform provides real-time data visualization, trend reporting, and automated alerts for out-of-range readings. RemetricHealth specializes in monitoring chronic conditions including congestive heart failure (CHF), hypertension, chronic obstructive pulmonary disease (COPD), and diabetes. The company is FDA-registered and ISO 13485–certified, ensuring regulatory compliance for its devices, portals, and applications. RemetricHealth operates a nursing team that performs patient assessments, provides wellness checks, medication adjustment coordination, patient education, and responsive follow-up via phone, text, and email. The solution is designed to reduce unnecessary hospital admissions and emergency department visits while improving patient engagement and clinical outcomes. The platform integrates with existing healthcare workflows and supports CPT-based reimbursement models for RPM and chronic care management services.

Nihon Kohden is a global medical device manufacturer headquartered in Japan with US operations in Irvine, California. The company specializes in interconnected clinical solutions spanning patient monitoring, ventilation, neurology diagnostics, and sleep medicine across the continuum of care—from ICU and critical care settings to perioperative environments, neurology labs, and sleep centers. Key product lines include the Life Scope® G5 bedside monitor (multiparameter monitoring with iNIBP, arrhythmia detection, QTc/QRSd analysis, and Smart Cable™ technology for parameter expansion); the NKV-550 ventilator system (supporting neonatal through adult patients with invasive/non-invasive ventilation and high-flow oxygen therapy, featuring Protective Control® and Gentle Lung® Suite); the AirEEG® wireless EEG system (clinical-grade wireless recording with 4,000 Hz sampling, automatic location detection, and dual-video review); and AlarmSense™ software (clinical analytics for alarm management with 90-day trend analysis and alarm modeling). Nihon Kohden emphasizes integrated data workflows, transport continuity during intra-hospital patient movement, and real-time clinical decision support. The company targets hospital systems across critical care, perioperative/surgical care, neurology, and sleep diagnostics. Products incorporate advanced monitoring parameters, wireless technology, and connectivity for seamless clinical documentation and team collaboration. The company maintains active engagement with major professional societies including SCCM, HIMSS, ASA, AARC, and AES, reflecting commitment to critical care, anesthesia, respiratory therapy, and neurology specialties. Regulatory compliance and clinical integration capabilities are core to the product portfolio.

Intuitive Surgical, Inc. is a global leader in robotic-assisted surgical systems and digital health solutions. The company manufactures the da Vinci family of robotic surgery platforms, which enable minimally invasive surgical procedures across multiple specialties including general surgery, urology, gynecology, cardiothoracic, and orthopedics. Core product lines include the da Vinci 5 (advanced integrated robotic platform with surgeon console and patient cart), the da Vinci SP (single-port robotic system for new surgical approaches), and the Ion robotic bronchoscopy system for lung cancer diagnosis and biopsy. Intuitive also manufactures da Vinci instruments and accessories designed for precision and ergonomic control. Beyond hardware, the company provides digital solutions including My Intuitive (data analytics and insights platform for surgical teams) and SimNow (surgeon training and simulation software). The company operates a global infrastructure with expanded direct operations in Europe and provides 24/7 service and support. Intuitive's systems are used in hospitals worldwide for minimally invasive surgery, and the company has established itself as the market leader in robotic-assisted surgical technology since its founding in 1995. The platform emphasizes surgeon autonomy, precision, and patient outcomes through advanced visualization and control systems.

MilliporeSigma is a global life sciences supplier offering laboratory chemicals, consumables, equipment, and services for research, biomanufacturing, and analytical testing. The company operates under multiple brand portfolios: Sigma-Aldrich provides research chemicals, solvents, reagents, reference materials, and labware; Millipore specializes in filtration products, membrane technologies, and biopharmaceutical manufacturing solutions; SAFC supplies pharmaceutical and biopharmaceutical raw materials; Supelco offers analytical chromatography products and standards; Milli-Q provides laboratory water purification systems and consumables; and BioReliance delivers contract testing and quality assurance services. Product lines include certified reference materials, microbial culture media, syringe filters, centrifugal devices (Amicon), filter membranes, pipette tips, glassware, cell separation media, water purification cartridges, and bioprocessing platforms. MilliporeSigma serves pharmaceutical development, biomanufacturing, clinical diagnostics, food and beverage testing, and academic research markets. The company emphasizes sustainability initiatives, offering greener alternative products and returnable solvent systems (ReCycler). Services include consultative workflow optimization and contract manufacturing support. Operations span multiple locations with comprehensive global distribution and customer support infrastructure.

DeRoyal Industries, Inc. is a global medical manufacturer founded in 1973, celebrating over 50 years of operations. The company manufactures and distributes a broad portfolio of healthcare products and solutions across wound care, orthopedic devices, surgical instruments, patient care equipment, and inventory management systems. Key product lines include NPWT (negative pressure wound therapy) systems, wound dressings, orthopedic supports and casting equipment, surgical consumables, and hospital furniture. DeRoyal operates Continuum®, an RFID-based inventory and charge capture system that improves accuracy and provides digital chain of custody for healthcare facilities. The company also provides OEM product manufacturing, metals fabrication, and sterilization services to healthcare partners. DeRoyal maintains manufacturing operations in Tennessee and distributes products to over 70 countries through its International Division. The company supports healthcare providers through multiple service channels including customer service, OEM partnership support, and 24/7 Continuum inventory management support. DeRoyal is recognized for quality and compliance standards in medical device manufacturing and has received recognition from Vizient for service excellence. The company serves hospital systems, surgical centers, long-term care facilities, and home health providers.

Delsys Inc. is a 30-year-old Massachusetts-based manufacturer of advanced wearable electromyography (EMG) systems and sensors for research, clinical diagnostics, and rehabilitation. The company specializes in wireless, real-time surface EMG technology with proprietary sensor designs and communication protocols optimized for human movement analysis, motor control research, neuromuscular physiology, and neurorehabilitation applications. Their primary product line—Trigno—comprises multiple system configurations (Centro for research-grade applications, Lite for entry-level systems, Link for integrated multimodal data acquisition, and HDsEMG for high-density motor unit analysis). Individual EMG sensors (Avanti, Mini, Duo, Quattro, Snap Lead) and auxiliary modules (Analog Adapter, FSR Adapter, Goniometer, Load Cell, EKG Biofeedback) enable customizable system builds. High-density EMG sensors (Galileo, Maize) support advanced motor unit decomposition and motor control studies. The Trigno ecosystem integrates with external research tools via a documented API and proprietary software (EMGworks, Trigno Discover, NeuroMap). Delsys serves academic institutions, medical research labs, rehabilitation facilities, exoskeleton/wearable robotics developers, and clinical diagnostics centers globally. Products emphasize low-noise signal acquisition, 40+ meter wireless range, intuitive data visualization and analysis workflows, and expandable architecture. The company provides remote and on-site training, technical support, and system integration services.

Syntermed, Inc. is a medical software company specializing in advanced diagnostic imaging analysis tools for nuclear cardiology, brain imaging, and PSMA PET/CT scanning. The company develops FDA-cleared, ISO 13485-certified software solutions that enhance clinical value and diagnostic accuracy across multiple imaging modalities. Primary product lines include the Cardiac Toolbox (eCTB), a comprehensive multi-modality platform for SPECT, PET, calcium scoring, myocardial blood flow, and strain analysis with integrated reporting and remote reading capabilities; NeuroQ 4, brain imaging analysis software for FDG-PET, Amyloid, SPECT, and DatScan imaging; and aPROMISE, a deep learning application for quantitative PSMA PET/CT assessment. Syntermed Live enables remote, cloud-based reading and reporting for nuclear cardiology studies. The company's Smart Scores technology provides automated quantitative segmental analysis with natural language report generation and physician decision support. Products are designed for nuclear medicine departments, cardiology practices, and neuroimaging centers. Syntermed has been the exclusive licensee of the Emory Cardiac Toolbox for over 25 years and recently acquired the intellectual property rights. The company maintains FDA Quality System Records and Pre-Market Notification (510(k)) clearance, along with European Union CE Mark (ISO 13485:2016) certification. All medical devices comply with applicable regulatory frameworks for diagnostic imaging software in the United States and European markets.

Vantive is an independent healthcare company specializing in vital organ therapies, with a 70-year legacy in kidney care products and services. The company develops and markets dialysis equipment, continuous renal replacement therapy (CRRT) systems, and extracorporeal carbon dioxide removal (ECCO2R) technology for acute care settings. Vantive's product portfolio includes peritoneal dialysis systems such as HomeChoice, hemodialysis platforms, and advanced therapies like PrismaLung+ for ARDS management. The company serves chronic kidney disease patients and acute care settings through three integrated pillars: therapies (innovative medical devices for kidney and organ support), digital solutions (software platforms to optimize care quality and efficiency), and advanced services and education (clinician training and patient support programs). Vantive operates across home-based therapies, in-center dialysis, and acute care markets. The company emphasizes coordinated care ecosystems and patient-centric treatment options including home dialysis modalities. Manufacturing and R&D capabilities support clinical research and regulatory submissions. Vantive prioritizes evidence-based innovation with publications in peer-reviewed journals and presentations at major nephrology conferences. The organization serves patients, caregivers, and clinical teams with comprehensive support resources and medical information services.

C-RAD is a global medical device company specializing in Surface Guided Radiation Therapy (SGRT) solutions for cancer treatment. The company develops and manufactures patient-centric, user-friendly positioning and guidance systems that enable precise radiotherapy treatments and improve clinical outcomes in oncology. C-RAD's primary product lines include the Catalyst+ platform (available in HD, LITE, PT, and HD Ring Gantry configurations), the Sentinel 4DCT system for 4D imaging during treatment, cAutoVerify automated verification software, and Visual Coaching Solutions for patient guidance. These systems deliver real-time surface imaging and tracking to ensure treatment accuracy, reduce setup errors, and enhance workflow efficiency in radiation therapy departments. The company serves cancer treatment centers, hospitals, and clinics globally through direct sales offices in Sweden, Germany, France, USA, Australia, China, and India, as well as through regional distributors. C-RAD emphasizes interoperability with existing linear accelerators and treatment planning systems, system reliability, ease of use, and comprehensive technical support. The company maintains global service support groups for installation, clinical implementation, preventive maintenance, and software upgrades throughout the product lifecycle.

Heidelberg Engineering GmbH is a global leader in ophthalmic imaging and data solutions, founded in 1990 and trusted by eye care professionals in over 120 countries. The company specializes in high-precision diagnostic imaging systems for anterior and posterior segment ophthalmology, coupled with integrated healthcare IT solutions optimized for eye care workflows. Core product portfolio includes SPECTRALIS (multimodal retinal imaging platform), ANTERION (anterior segment imaging platform), Heidelberg Eye Explorer (ophthalmology-specific healthcare IT), and a fully digital surgical visualization platform. These solutions enable early disease detection, visualization of subtle retinal and anterior segment changes, treatment guidance, and reproducible high-definition imaging with seamless clinical infrastructure integration. The company operates a robust global support infrastructure with multilingual service capabilities and distributes products across diverse markets including academic medical centers, private practices, and research institutions. Heidelberg Engineering operates the Heidelberg Engineering Academy, providing over 20 years of continuous clinical education, hands-on training, and on-demand learning resources for eye care professionals worldwide. The company demonstrates strong commitment to scientific innovation through collaboration with leading research institutions and participation in major ophthalmic symposia (ISS, ARVO). Manufacturing and regulatory certifications align with medical device standards for ophthalmology markets.

BRAEBON MEDICAL CORP. is a Canadian manufacturer of polysomnography (PSG) sensors, home sleep testing (HST) systems, sleep diagnostic devices, and dental sleep medicine solutions. Over 20 years, the company has developed a portfolio of over 140 products serving sleep labs, cardiologists, dentists, and home-based sleep disorder screening. Core product lines include the MediByte and MediByte Jr. Level 3/4 portable sleep recorders, DentiTrac oral appliance compliance monitoring technology, and an extensive range of PSG sensors including airflow, nasal pressure, and thermistor sensors. BRAEBON also offers cloud-based workflow management software for intake-to-treatment coordination and disposable sensor alternatives. The company serves international markets across six continents. All products comply with U.S. FDA, Health Canada, European CE, IEC 60601, and Australian TGA standards. BRAEBON holds ISO 13485 certification and CE marking. The company emphasizes rapid technical support, industry-leading warranties, and equipment replacement programs. Primary markets include sleep medicine laboratories, hospital cardiology departments screening for sleep apnea, and dental professionals monitoring oral appliance therapy effectiveness. Manufacturing is conducted in Canada.

Chungdo Pharm. Co., Ltd. is a South Korean in-vitro diagnostic (IVD) medical device manufacturer specializing in urine test strips and diagnostic analyzers. The company develops and manufactures a comprehensive portfolio of diagnostic test strips for human and veterinary use, including Self-Stik series urine strips for diabetes, kidney function, liver health, urinary tract infection, calcium, vitamin C, nitric oxide, and oxidative stress monitoring. For veterinary applications, the company offers Self-Stik VET series strips customized for seven animal species (dogs, cats, cattle, horses, goats, sheep, pigs), as well as specialized veterinary products including kidney care, sugar care, liver care, and stone care monitoring strips. The company also manufactures AnyScan urine analyzers (CK-60, AnyScan 300, AnyScan 720) with varying throughput capacities (60–720 samples per hour), featuring PC data integration and patient management system compatibility. Additional products include control solutions (CK-Trol), Yocheck smartphone-connected veterinary urine analyzers, and emerging product lines for sodium monitoring and home diagnostic tools. Chungdo Pharm exhibits globally at major trade shows (KIMES, MEDLAB, AACC) and conducts R&D in drug/alcohol testing, lactate, uric acid, and nicotine detection. The company maintains FDA regulatory engagement and ISO compliance standards typical of IVD manufacturers serving clinical laboratories, hospitals, veterinary clinics, and home-use consumers.

Fujirebio Holdings, Inc. is a subsidiary of H.U. Group Holdings Inc. that specializes in in vitro diagnostics (IVD) biomarker innovation and Contract Development & Manufacturing Organization (CDMO) services. The company drives the biomarker-to-IVD journey through research, clinical validation, and manufacturing partnerships, with a focus on transformative diagnostic solutions across multiple disease areas. Fujirebio's core offering includes the Lumipulse® platform, a fully automated immunoassay system for clinical laboratory testing, alongside manual and semi-automated assay kits (INNO-LIA®, INNO-LiPA®, INNOTEST®, CanAg®). The company manufactures diagnostic instruments, assay kits, software (LIRAS®), quality controls, and raw materials (antibodies and antigens). Primary clinical specialties include neurodegeneration (Alzheimer's disease, multiple sclerosis, Parkinson's disease, ALS), with blood-based biomarkers for amyloid and phosphorylated tau; infectious diseases (HPV genotyping, HPV screening); autoimmune disorders; cardiac markers; tumor markers; fertility and endocrinology; diabetes; and bone metabolism. Recent FDA clearances include blood-based Alzheimer's disease diagnostic tests. The company maintains regulatory credentials including FDA 510(k) clearances and CE marking. Fujirebio operates globally with CDMO partnerships, providing diagnostic raw materials, reagents, and full development and manufacturing services to technology partners and clinical laboratories.

PTW Freiburg is a family-owned global leader in dosimetry solutions for radiation medicine, with over a century of expertise. The company specializes in four core markets: radiation therapy, diagnostic radiology, metrology, and radiation monitoring. PTW develops and manufactures automated water phantoms (BEAMSCAN family), web-based quality assurance platforms (UNICHECK), modular patient QA systems (VERIQA), and AI contouring quality monitoring software (AIQUALIS). The company operates three manufacturing sites with 90% in-house development and production capability, employs approximately 450 staff worldwide, and maintains 12 international branch offices serving radiation experts across more than 160 countries. PTW operates one of the largest independent dosimetry calibration laboratories globally, performing over 12,000 calibrations annually in ionizing radiation. The company also provides comprehensive training through the PTW Dosimetry School, offering physical and virtual seminars, workshops, and webinars in multiple languages. Regulatory credentials and certifications are not explicitly detailed in available content, though the company emphasizes commitment to quality and sustainability, achieving EcoVadis Silver Medal recognition (top 10% sustainability rating). Manufacturing capability includes water phantom systems, software platforms for treatment planning QA, and calibration services.

CHG-MERIDIAN is a global technology-as-a-service company founded in 1979, headquartered in Weingarten, Germany. Operating in 32 countries with over 1,400 employees, the company manages a €10 billion technology portfolio through a circular economy model. CHG-MERIDIAN specializes in customized financing, leasing, and lifecycle management solutions for IT, industrial, and healthcare technology assets. The company enables enterprises to access cutting-edge equipment through usage-based models rather than ownership, eliminating capital expenditure barriers. Core offerings include IT hardware deployment (desktops, laptops, enterprise mobility), industrial equipment management (production, warehouse, logistics machinery), and healthcare technology solutions (medical diagnostic and imaging equipment financing). CHG-MERIDIAN's integrated end-to-end asset management platform covers procurement, deployment, monitoring, refurbishment, and resale. The company's proprietary tesma® platform provides data access and self-service ordering, while devicenow offers device-as-a-service models. By emphasizing sustainability and circular economy principles, CHG-MERIDIAN reduces total cost of ownership while supporting customers' ESG objectives across 190 countries through subsidiaries and partners.

PharmaCaribe develops and commercializes novel pharmaceutical and medical device solutions with streamlined regulatory pathways for rapid market entry. The company specializes in hypertonic saline inhalation solutions, including flagship products PulmoSal and NebuSal, formulated to USP standards with FDA-cleared (pH+) Bio-Balanced™ formulations. These solutions are designed for respiratory applications, including cystic fibrosis management and potential prophylactic/therapeutic applications for viral respiratory infections. The company combines clinical research with abbreviated development timelines to bring evidence-based respiratory therapeutics to market.

Dentsply Sirona is a global leader in dental equipment, devices, consumables, and software solutions serving dental practices and laboratories. The company operates in 150+ countries with over 4,000 customer service representatives and maintains an extensive portfolio spanning digital dentistry, implant systems, endodontics, restorative materials, orthodontics, and imaging solutions. Key product lines include CEREC CAD/CAM milling units (Primemill, Primemill Lite, Go) for chairside restoration manufacturing; Primescan 2 intraoral scanner; Axeos extraoral imaging systems; DS Core cloud-based platform for digital workflows; implant systems including EV family; endodontic instruments (X-Smart Pro+, ProTaper Ultimate); restorative materials (SDR flow+); and comprehensive practice management and imaging software. The company invested over 4% of annual revenue in R&D with 650+ scientists and engineers, maintaining innovation across 130+ years of operational history. Dentsply Sirona serves dental practices, labs, and healthcare professionals with integrated hardware and software ecosystems designed for connected dentistry workflows. The company provides extensive training, continuing education, and practice management support through DS Academy, clinical courses, and direct specialist consultation.

Thermo Fisher Scientific is a global leader in life sciences and laboratory equipment, consumables, and digital solutions. The company manufactures and distributes a comprehensive portfolio of products for research, diagnostics, and bioprocessing applications across academic, pharmaceutical, biotechnology, and clinical laboratory markets. Product lines include transmission electron microscopes (Glacios 3 Cryo-TEM for structural biology), cell culture media and supplements (Gibco brand), molecular biology reagents (TaqMan and SuperScript PCR systems), transfection reagents (Lipofectamine), assay kits, fetal bovine serum, laboratory consumables (tubes, plates, magnetic beads), and analytical instruments. The company serves drug discovery, genomics, proteomics, cell culture, viral production, and materials analysis workflows. Thermo Fisher operates a robust e-commerce platform with online ordering of thousands of SKUs, technical support resources, interactive media selection tools, and educational content. The organization maintains ISO certifications and FDA compliance for its clinical and diagnostic products, with manufacturing facilities and distribution networks across North America and globally.

Welldoc is a digital health platform company specializing in AI-driven chronic disease management, with a focus on diabetes, hypertension, heart failure, obesity, and behavioral health. Founded in 2005 by an endocrinologist, Welldoc delivers clinically-validated, evidence-based solutions that integrate personalized, real-time insights into patient workflows. The flagship product, BlueStar® (FDA-cleared prescription digital therapeutic), provides automated patient coaching and real-time guidance for adults with type 2 diabetes. Welldoc's platform enables "care anywhere" delivery models for health plans, healthcare systems, and employers, integrating disparate health data into actionable clinical insights across the cardiometabolic spectrum. The company collaborates with major partners including Abbott, CVS Health, Eli Lilly, Dexcom, and others, leveraging data science and behavioral algorithms to improve medication adherence, lifestyle change, and self-management outcomes.

Abingdon Health plc is a UK-based public limited company specializing in contract research, development, and manufacturing of lateral flow assay diagnostic tests. Headquartered at York Biotech Campus with operations in Doncaster, UK and Madison, Wisconsin, the company serves global clients across healthcare, animal health, and plant health sectors. Abingdon Health offers comprehensive lateral flow services from concept to commercial launch, including contract LFT development, scale-up and technical transfer, contract manufacturing, regulatory consultancy, quality assurance, analytical testing, and commercial support. The company provides flexible manufacturing solutions encompassing reagent preparation, spraying, lamination, kitting, assembly, and final batch release. Notable products include SaliStick, the world's first saliva-based pregnancy test, and the Simply Test range of self-tests. With expertise in biomarker validation, FDA PMA submissions, IVD and companion diagnostic development, Abingdon Health supports clients through complex regulatory pathways and large-scale manufacturing operations.

BrightInsight is a cloud-based digital health platform company serving biopharma and medtech organizations. The company specializes in developing and maintaining regulated digital health solutions, including Software as a Medical Device (SaMD), companion patient apps, connected medical devices, clinical algorithms, and healthcare provider interfaces. The BrightInsight Platform provides a configurable, enterprise-grade solution that enables faster time-to-market while ensuring compliance with global regulatory standards. The company has delivered 14 SaMD solutions across 11 therapy areas and partners with 6 of the top 10 biopharma firms. Core capabilities include real-world data collection, patient engagement tools, clinical outcome analytics, and disease management solutions. BrightInsight addresses the critical business need for regulated digital health deployment, helping life sciences companies differentiate therapies, improve patient adoption and retention, and unlock real-world evidence from connected digital health ecosystems.

Augmedit is a medical software company specializing in augmented reality (AR) technology for surgical procedures, medical education, and patient engagement. The company transforms 2D medical imaging data (CT and MRI scans) into interactive 3D holographic models, primarily compatible with Microsoft HoloLens 2. Augmedit's platform enables surgeons and clinical teams to conduct pre-operative planning, intra-operative guidance, and patient education using patient-specific holograms. The core product portfolio includes Lumi (cloud-based DICOM-to-3D conversion for 3D labs and researchers), LumiNE Lite (neurosurgical planning with automatic anatomical segmentation), and LumiNE Elite (intra-operative visualization with precise hologram-to-patient registration). Applications span neurosurgery, cranio-maxillofacial surgery, and emerging use cases in other surgical specialties. The subscription-based software integrates seamlessly into clinical workflows, supporting improved surgical outcomes, cost savings, and enhanced patient-clinician communication. Future developments include web and mobile platform compatibility.

Medicalgorithmics S.A. is a Warsaw-based, publicly listed (GPW) medical technology company founded in 2005, specializing in AI-powered, noninvasive cardiac diagnostic solutions. The company develops and manufactures a comprehensive suite of ECG monitoring devices and cloud-based software platforms that leverage advanced artificial intelligence to detect, classify, and analyze cardiac arrhythmias. Key product offerings include PocketECG (full-disclosure mobile cardiac telemetry with rich diagnostic reporting), Kardiobeat.ai (wearable 24–18 day Holter monitor with AI-driven analysis), DeepRhythm Platform (DRP) – a hardware-agnostic cloud ECG platform with FDA clearance and Health Canada licensing – DeepRhythmAI (DRAI) for rapid arrhythmia detection across third-party devices, and Virtual Cardiac Stress Test (VCAST), an advanced CT-based diagnostic tool for coronary artery assessment. All core products carry FDA 510(k) clearance, EU MDR certification, and Health Canada approval. The company serves cardiologists, healthcare systems, and clinical research organizations across North America, Europe, and Asia-Pacific, with an extensive annotated heartbeat library supporting over 100 arrhythmia types. Medicalgorithmics also provides R&D services, clinical trial support, and scientific research partnerships focused on cardiovascular disease diagnosis.

Nonin Medical, Inc. is a global leader in designing and manufacturing noninvasive physiological monitoring solutions. Founded in 1986 and headquartered in Plymouth, Minnesota, the company serves clinicians and consumers in over 125 countries. Nonin pioneered the world's first portable hand-held pulse oximeter and fingertip pulse oximeter, and was the first to integrate Bluetooth technology in pulse oximetry devices. The company's core product portfolio includes pulse oximeters (fingertip, wrist-worn, and handheld), regional/cerebral/somatic tissue oximeters, capnographs, and associated sensors. Nonin's proprietary PureSAT pulse oximetry technology provides accurate readings even in challenging conditions with motion, low perfusion, or variable skin tones. Primary customers include emergency medical services, hospitals, clinics, long-term care facilities, home healthcare providers, and OEM manufacturers who integrate Nonin components into their own medical devices. The company recently introduced the Nonin Health® platform, a cloud-based data management system enabling remote access to pulse oximetry results for improved workflow efficiency and clinical decision-making.

Hearts Bio is a California-based medical device and wellness company offering an integrated ecosystem for health management through diet, fitness, and self-monitoring. The HeartsCare product line comprises portable, Bluetooth-enabled diagnostic meters for at-home testing of cholesterol, glucose, lactate, and ketone levels—each with rapid results and data logging capabilities. HeartsFit provides fitness equipment including performance bicycles. HeartsDiet supplies food weighing scales for dietary tracking. The company also develops HeartsHome, a 3D mobile application (iOS/Android) that aggregates health metrics and test results in an interactive dashboard. HeartsCubeAI represents precision medicine and genomic AI in development. Hearts Bio targets individuals managing chronic disease risk factors (heart disease, diabetes, cancer) and fitness-focused consumers seeking integrated home health monitoring and lifestyle management tools.

Dental Crafters is a full-service dental laboratory based in Marshfield, Wisconsin, specializing in restorative dentistry and implant solutions. The company offers a comprehensive range of products including crowns, fixed and removable denture prosthetics, custom abutments, tissue formers, and implant-supported restorations. Part of the Dental Crafters Network (which includes Implant Solutions and Dental USA), the organization provides digital workflow solutions including the Shining Intraoral Scanner for high-definition dental scanning, eliminating traditional impression methods. Additionally, Implant Solutions—the surgical planning subsidiary—delivers surgical guides and planning services to support predictable implant placement for dental practitioners. ISO 13485 certified, the company combines traditional craftsmanship with modern CAD/CAM technology and digital photogrammetry to deliver precision restorations and custom dental solutions to dentists and their patients.

LaCAR MDx Technologies is a Belgian biotechnology company specializing in CE-IVD certified diagnostic kits and integrated solutions for genetic testing. The company develops and manufactures comprehensive laboratory solutions covering newborn screening (early detection of congenital and metabolic diseases), pharmacogenetics (treatment optimization based on genetic profiles), and genetic predisposition/disorder diagnostics. LaCAR MDx offers an end-to-end platform combining diagnostic kits, qPCR and LAMP-based instruments, and interpretation software (GeneFoxCub). ISO 13485 compliant, locally produced in Liège, the company serves over 250 clients across 50+ countries, emphasizing quality, automation, and responsive customer support for laboratory workflows from sample processing to result analysis.

exocad is a leading provider of dental CAD/CAM software solutions for digital dentistry. Founded in 2010 and headquartered in Darmstadt, Germany, the company serves over 70,000 customers across 150 countries through a global reseller network. The company specializes in open-platform, hardware-neutral software designed for dental laboratories, practices, and enterprise DSOs. exocad's modular approach offers flexibility in licensing (perpetual licenses or rental models) and seamless integration with third-party scanners, mills, printers, and materials. Key products include DentalCAD for crown-and-bridge restorations and implant planning, PartialCAD for removable prosthetics, ChairsideCAD for in-office digital workflows, exoplan for surgical guide design, and Smile Creator for esthetic visualization. The platform incorporates AI-driven automation and guided workflows to enhance efficiency and consistency. exocad emphasizes speed, ease of use, reliability, and future-proof innovation, with continuous product updates driven by customer feedback.

CandidPro is a doctor-directed clear aligner orthodontic platform operated by Candid Care Co. Launched in 2022, the platform provides dental professionals with integrated treatment planning software, custom clear aligners, and patient monitoring tools. The system features CandidMonitoring™, an app-based at-home progress tracking system enabling virtual oversight every 1–2 weeks. CandidPro delivers full aligner sets customized to individual patient needs, adjustable every 1–2 weeks, plus premium whitening foam and retainer products. The platform integrates with existing dental software workflows and emphasizes a doctor-directed approach to orthodontic care, targeting common bite misalignments and supporting long-term oral-systemic health outcomes. Supported by a network of dentists and orthodontists, CandidPro combines advanced appliance manufacturing with digital tools to enhance treatment efficiency and patient compliance.

Kolibree develops smart electric toothbrushes and connected oral care systems designed for children aged 5–10. The system comprises a pressure-sensing toothbrush with replaceable heads, a mobile app featuring augmented reality gamification, and a parent dashboard for tracking brushing coverage and technique. The AR-guided app coaches proper brushing technique by visualizing tooth zones and rewarding complete coverage, helping children achieve the recommended 2-minute brushing duration and reduce missed zones (particularly back molars). Built-in sensors detect brushing movements and unlock interactive games; the app displays coverage scores, identifies underserved tooth areas via heatmaps, and allows parents to share reports with dentists. Kolibree emphasizes cavity prevention, habit formation, and stress-free family routines through guided, gamified oral hygiene. Products include monthly and annual subscription tiers with automatic refill delivery of brush heads every six months.

InkWell Health provides a first-of-its-kind Remote Therapeutic Monitoring (RTM) platform using wearable temporary tattoo technology to enable real-time tracking of musculoskeletal recovery. The system allows orthopedic surgeons and physical therapists to monitor patient progress—including swelling, temperature, range of motion, and wound healing—from home while generating medical-grade data to optimize individualized recovery plans. The accompanying mobile application guides patients through their post-surgical or post-injury rehabilitation with daily tracking and clinician alerts, improving patient compliance, clinical outcomes, and operational efficiency. Designed for outpatient orthopedic surgery recovery and physical therapy settings, InkWell Health bridges the gap between in-clinic care and home recovery monitoring, reducing post-operative complications and enhancing patient satisfaction with their healing journey.

Hemanext Inc. is a medical technology company based in Lexington, Massachusetts, specializing in advanced blood preservation and transfusion medicine solutions. The company's flagship product, Hemanext ONE®, is an FDA-authorized oxygen-controlled processing and storage system designed to preserve red blood cell (RBC) quality during refrigerated storage for up to 42 days. By removing and maintaining low oxygen levels throughout storage, Hemanext ONE® reduces oxidative storage lesions—progressive metabolic and structural damage that degrades RBC function and oxygen delivery capacity. The system preserves critical RBC parameters including membrane integrity, deformability, and metabolic stability, resulting in higher-quality blood products that maintain closer-to-physiological function. This innovation is particularly valuable for chronic transfusion patients (such as those with sickle cell disease) requiring lifelong transfusions, as well as trauma and resuscitation settings where blood quality directly impacts clinical outcomes. Hemanext operates on a consumable model facilitating seamless integration into existing hospital and blood center workflows, with CMS reimbursement recognition reflecting the clinical and economic value of oxygen-controlled RBC units.

PharmAdva develops the MedaCube, a clinically validated automatic medication dispenser designed to improve medication adherence for seniors, caregivers, and healthcare providers. The device holds up to a 90-day supply of 16 medications and features audio/visual dispensing alerts, caregiver notifications for missed or late doses, refill alerts, tamper-proof security with metal lock, touchscreen interface, WiFi/cellular connectivity, real-time photo documentation of each dose, and backup battery. The MedaCube has demonstrated industry-leading results in published clinical trials and addresses the estimated $300B annual medication adherence challenge in the U.S. Designed for patients with dementia and aging individuals seeking to maintain independent living, the device integrates cloud-based medication management with no monthly subscription fees. Over 100 million pills have been dispensed using the MedaCube platform since commercial launch in 2016.

Tasso Inc. is a Seattle-based healthcare technology company founded in 2014 that specializes in transforming at-home blood collection through innovative, patient-centric devices. The company offers an end-to-end platform for decentralized clinical trials and remote blood sample collection, eliminating the need for traditional phlebotomy and venipuncture. Tasso's proprietary devices—Tasso+ and Tasso Mini—enable virtually painless capillary blood sampling, improving patient experience and engagement while reducing collection anxiety. The Tasso+ device collects whole liquid blood compatible with standard collection tubes, while Tasso Mini is optimized for longitudinal sampling, frequent testing, and sensitive populations including pediatrics. Beyond hardware, Tasso provides comprehensive logistics support including sample shipping, live proctoring, SMS reminders, and lab integration. The platform supports diverse clinical applications including population pharmacokinetic (PopPK) studies, clinical trial prescreening, pediatric research, and anti-doping testing. Tasso has established partnerships with major laboratories and healthcare organizations such as ARUP Laboratories and InnoVero, and is cited in over 100 peer-reviewed publications. The solution addresses critical barriers to diagnostic access, particularly in decentralized and remote care settings.

iTonic is an AI-powered home health platform that serves as the operating system for connected care across patients, families, and healthcare providers. The platform integrates smart medication management, remote patient monitoring, and an emotionally-intelligent AI companion (SAVi) that delivers voice-enabled check-ins, personalized health coaching, and behavioral engagement. The system includes family and provider dashboards offering real-time visibility and transparency across the circle of care. iTonic targets seniors, veterans, Medicare/Medicaid populations, and senior living facilities, with demonstrated clinical outcomes including 30% reduction in hospital readmissions, 40% higher patient engagement, and 10% improvement in medication adherence. The modular, interoperable platform is designed to integrate with existing medical devices and healthcare systems while prioritizing intuitive, human-centered user experience across intergenerational care teams.

HeartBeam, Inc. is a medical technology company specializing in portable, cable-free electrocardiogram (ECG) solutions for ambulatory cardiac monitoring. The company's proprietary Vector Electrocardiography (VECG) technology captures three-dimensional cardiac electrical activity and synthesizes clinical-grade 12-lead ECGs using the HeartBeam AIMIGo device—a credit card-sized, patient-friendly tool. The HeartBeam System integrates a mobile app with cloud-based infrastructure and on-call cardiologist interpretation, enabling patients to record and transmit ECG data from home or any location for rapid clinical review. Founded in 2015 and holding over 20 patents, HeartBeam targets detection and monitoring of cardiac diseases in both professional healthcare and personal-use settings. The system is positioned as an FDA-cleared alternative to traditional in-clinic ECG acquisition, with integration partnerships including HeartNexus for cardiologist networks. Applications span remote patient monitoring, telehealth diagnostics, and at-home arrhythmia detection.

Kusmo develops CaTHSTiX, an innovative catheter stabilization and placement support system designed for healthcare professionals across multiple specialties. The technology is engineered to improve catheter placement efficiency, reduce procedure time, and enhance patient comfort and safety. CaTHSTiX serves physicians, nurses, and clinical technicians in cardiology, interventional radiology, emergency medicine, intensive care, trauma surgery, anesthesiology, and cardiac electrophysiology. The platform includes educational resources and training materials (Kusmo Academy) tailored for clinicians, hospital administrators, and patients. The company is expanding internationally with localized content for Brazil and India.

Blue Sky Bio, LLC is a manufacturer and distributor of high-quality dental implant systems and related products, founded in 1998 and based in Libertyville, Illinois. The company specializes in providing compatible implant systems, advanced digital planning software, surgical and clinical equipment, and prosthetic accessories at competitive pricing. Blue Sky Bio operates with a lean business model that minimizes traditional sales and marketing expenses, redirecting resources toward superior engineering and manufacturing. The company offers four implant systems on a unified prosthetic platform, supplemented by Blue Sky Plan—a comprehensive software solution for surgical guide design, implant planning, and case management. Additional services include LabPronto laboratory case submissions with fast turnaround, comprehensive digital dentistry education through Blue Sky Bio University, and clinical support from experienced practitioners. Blue Sky Bio serves value-conscious dental practitioners and laboratories seeking quality implant solutions and workflow efficiency.

iWorx Systems manufactures advanced data acquisition, analysis, and physiology education solutions for academic and research institutions. The company provides integrated hardware and software platforms for teaching human, animal, exercise, and psychological physiology, as well as neurobiology and neuromuscular research. Core offerings include TA (Teaching Assistant) kits with pre-calibrated sensors, LabScribe data acquisition and analysis software, signal conditioners, stimulators, transducers, and electrodes. The TA-ROAM system features wireless ECG/EMG recording with built-in multi-modal sensors for simultaneous signal capture. iWorx also offers metabolic assessment carts for VO2max and resting heart rate measurement in fitness applications. All systems employ the company's proprietary iWire digital interface technology for plug-and-play expandability and extended system longevity. The company serves 93 of the top 100 U.S. colleges and 105+ institutions worldwide, supported by free software updates and comprehensive technical support.

Anatomage Inc. is a leader in advanced 3D medical virtualization technology founded in 2004. The company specializes in digitizing real human cadavers into interactive, fully functional 3D anatomical models called Anatomage Bodies, which provide ultra-high-definition, life-size representations of human anatomy, physiology, and pathology. Anatomage's flagship product, the Anatomage Table, is a life-size virtual dissection platform used for medical education, surgical planning, and clinical diagnosis. The company also offers complementary software solutions including Invivo5 for radiology and cloud-based learning platforms. With products deployed across 4,000+ healthcare and educational institutions in over 20 countries, Anatomage supports anatomy education, clinical training, surgical planning, and medical research. The platform enables visualization of anatomical variations, real-time physiological simulations, and practice of clinical procedures on digitized cadavers, significantly reducing medical errors and enhancing educational outcomes.

Cambridge Cognition is a neuroscience technology company specializing in digital cognitive assessment platforms for central nervous system (CNS) clinical trials. With over 30 years of scientific validation and expertise, the company provides an end-to-end solution for pharmaceutical companies, contract research organizations, and academic institutions. Core offerings include CANTAB® touchscreen cognitive assessments, voice analysis for verbal cognitive testing, electronic questionnaires and scales, high-frequency testing capabilities, decentralized clinical trial management, and automated quality assurance for clinical scales. The platform supports remote patient monitoring and decentralized trial recruitment, enabling drug developers to conduct cognitive efficacy and safety assessments in clinical or home settings. Cambridge Cognition's assessments have been validated across 3,000+ peer-reviewed publications and 250+ disease indications, including Alzheimer's disease, ADHD, depression, Parkinson's disease, multiple sclerosis, and schizophrenia. The company serves as a trusted partner for detecting subtle cognitive changes and generating objective biomarkers to accelerate brain health research and drug development timelines.

Cogstate Ltd is a neuroscience solutions company specializing in digital cognitive assessment platforms for clinical research and healthcare. Founded in 1999, the company provides validated, computer-based cognitive testing tools designed to measure brain health across connected devices. Cogstate's offerings include digital cognitive assessments, remote assessment capabilities for decentralized clinical trials, endpoint data quality services (rater training and monitoring), and healthcare cognitive screening solutions for clinical care settings. The company supports biopharmaceutical companies and academic institutions in clinical trials across 100+ indications, serving researchers worldwide. With 25 years of expertise, Cogstate has administered over 2 million digital tests and completed 35,800+ rater trainings. The platform is culture-neutral and optimized for precision in pharmaceutical studies, early-phase safety assessments, and cognitive impairment evaluation across conditions including Alzheimer's disease, Parkinson's disease, schizophrenia, and concussion. Cogstate's solutions are applied in neurology, sports medicine, and pharmaceutical development.

BioSignal is a neurodiagnostic company specializing in functional brain assessment via portable EEG technology. The company's FDA-approved microEEG® solution is a miniature, wireless clinical platform enabling rapid electroencephalogram (EEG) recording with cloud-based remote interpretation. BioSignal serves traditional neurology settings (epilepsy centers, sleep labs, neurology departments, ICUs) and expands brain function assessment into novel environments including emergency departments, NICUs, physician offices, ambulances, and home care. The platform supports sports concussion management, traumatic brain injury assessment, routine EEG monitoring, and STAT EEG capabilities. Applications span clinical neurology, emergency medicine, pediatric critical care, sleep medicine, sports medicine, and home sleep monitoring. The solution combines hardware portability with interpretive software to enable rapid assessment and telemedicine-capable EEG interpretation.

NuWav Labs is a CLIA-certified, COLA-accredited clinical laboratory offering comprehensive diagnostic solutions including core laboratory testing (chemistry, hematology, immunology), molecular diagnostics (COVID-19, Flu A/B, RSV), and high-quality reagents and kits for healthcare providers and diagnostic laboratories. The company specializes in fast turnaround times with 99% accuracy across 500+ test types, operating under HIPAA compliance and federal regulatory standards. NuWav serves as a scalable diagnostic partner for hospitals, clinics, and research institutions requiring reliable laboratory testing and reagent supply.

BodyTrace develops cellular-enabled weight scales and M2M connectivity solutions for digital health and medical device manufacturers. The company provides integrated cellular modems with global wireless coverage, enabling medical devices to function out-of-the-box without setup, pairing, or manual configuration. BodyTrace's platform handles connection management, AES encryption, remote provisioning, and automated billing, allowing manufacturers to reduce time-to-market to weeks while minimizing development complexity. The solution supports minimal code footprint implementation across microcontroller and ARM-based systems, with sub-$10 bill-of-materials cost and $1.50-2.00 monthly connectivity fees for typical M2M scenarios. Global network access eliminates need for multiple carrier contracts, SIM card management, and region-specific device provisioning, making BodyTrace a B2B platform for connected medical device manufacturers seeking simplified, secure, scalable cellular infrastructure.

ClariMed, Inc. is a global regulatory and human factors consulting firm headquartered in Chadds Ford, Pennsylvania, with offices across North America and Europe. Founded in 2022, the company specializes in user-centered design, human factors engineering, and quality management solutions for medical devices, combination products, and in-vitro diagnostics. ClariMed provides comprehensive end-to-end services including user needs assessments, contextual inquiries, human factors validation testing, regulatory compliance support, Quality Management System (QMS) implementation, UI/UX design, cybersecurity solutions, and strategic advisory services. The firm's multidisciplinary team brings expertise in human factors, industrial design, biomedical engineering, psychology, and quality engineering. ClariMed is ISO 13485:2016 certified and offers flexible engagement models—project-based consulting, embedded resources, retainer, and end-to-end support—to help MedTech and pharmaceutical companies accelerate time to market while ensuring safety, efficacy, and user satisfaction.

Austco Healthcare Limited is a global provider of healthcare communication solutions and clinical workflow management technology, headquartered in Port Melbourne, Australia. Established in 1986, the company serves over 5,000 healthcare facilities in more than 60 countries across six continents. The company's primary offering is the Tacera platform, an IP-based nurse call system and sophisticated communications platform that integrates advanced nurse call systems, mobile communications, real-time location services (RTLS), clinical workflow solutions, enterprise reporting and analytics, and system integrations. Tacera is designed for both acute care hospitals and aged care facilities, providing customizable solutions that enhance communication and operational efficiency. Additional offerings include Pulse Mobile (native mobile app for alarm management and VOIP calling), Pulse Reports (enterprise reporting and analytics), and touchscreen workflow stations for streamlined clinical communication. Austco is committed to innovation and interoperability, with full IP-based architecture that supports seamless integrations and future-proofs healthcare facility investments.

MyCareTeam develops MCT-Diabetes, a comprehensive diabetes monitoring and management platform designed to improve health outcomes and reduce overall healthcare costs. The solution facilitates communication and real-time monitoring between patients, caregivers, and healthcare professionals, enabling better disease management between clinical visits. MCT-Diabetes is marketed to three primary user groups: family caregivers seeking to support loved ones with diabetes regardless of location; healthcare professionals aiming to enhance patient quality of life through inter-visit monitoring and engagement; and organizations incorporating diabetes management into corporate wellness and employee health programs. The platform is offered on flexible monthly and yearly subscription models, making it accessible for individual and enterprise-level adoption.

ARxIUM is a global leader in pharmacy automation and workflow solutions with over 30 years of experience enhancing pharmacy operations. Headquartered in Winnipeg, Manitoba and Buffalo Grove, Illinois, ARxIUM serves health systems, long-term care facilities, retail, and hospital pharmacies worldwide. The company specializes in end-to-end medication management automation, inventory optimization, and pharmacy workflow digitalization. Core offerings include robotic IV compounding automation (RIVA System), central fill and mail-order solutions, automated dispensing cabinet networks, medication packaging and vial filling systems, and a comprehensive inventory management platform with real-time visibility and performance analytics. ARxIUM's solutions address critical pharmacy challenges including medication safety, operational efficiency, compliance tracking (DSCSA), waste reduction, and cost optimization through intelligent automation and seamless system integration.

PreOmics GmbH is a German proteomics company specializing in sample preparation solutions, automation platforms, and liquid chromatography tools for mass spectrometry-based protein and peptide analysis. Founded in 2016, the company provides an integrated ecosystem of consumables (iST kits, BeatBox® homogenizers, ENRICH enrichment technologies), automation platforms (APP96™ for high-throughput processing, PreON® for mid-throughput workflows), high-performance LC columns (PepSep®), and data visualization software (ProteoVision™). PreOmics solutions address applications in drug discovery, biomarker analysis, plasma proteomics, and high-throughput proteomics, serving pharmaceutical, biotech, academic, and clinical research laboratories globally. The company also offers CRO services and third-party automation integration with Agilent, Beckman, Hamilton, Opentrons, and Tecan platforms.

Elevaris Medical Devices is a Contract Development and Manufacturing Organization (CDMO) specializing in precision medical device development and manufacturing. Formed from the merger of Spectra Medical Devices and XL Precision Technologies, the company combines engineering expertise with advanced manufacturing capabilities in precision micro-components, complex tubular components, and sub-assemblies. Elevaris is recognized as one of the world's leading manufacturers of made-to-spec procedural needles, including epidural, spinal, echogenic, Huber, and FNA biopsy needles. The organization provides comprehensive services including engineering design, contract development, precision manufacturing, cleanroom assembly, and regulatory compliance support. With over 300 employees across facilities in North America, the UK, and South Korea, and serving 200+ clients globally with 30 years of combined experience, Elevaris supports multinational healthcare companies, OEMs, startups, and emerging technology firms. Manufacturing capabilities include laser technology, micro-machining, injection molding, precision forming, grinding, insert molding, metal finishing, and cleanroom assembly. The company is FDA-registered, ISO 13485:2016 certified, and maintains Class 7 cleanroom facilities.

NeoSoft, LLC is a cardiac MRI software company headquartered in Pewaukee, Wisconsin, founded in 2004 by Dr. Steven D. Wolff. The company specializes in advanced cardiovascular post-processing software that streamlines cardiac MRI analysis and reporting. The flagship product, suiteHEART®, is a vendor-agnostic software suite featuring zero-click preprocessing, semi-automated segmentation, and an intuitive interface designed specifically for cardiac MR workflows. The platform significantly reduces analysis time (reportedly up to 80–90% per clinical feedback) and includes comprehensive analysis modules for function, flow, myocardial evaluation, T1/T2 mapping, perfusion, strain, 4D flow visualization, and specialized assessments. suiteHEART® is FDA-cleared (510k #K130228), CE-marked, and registered in multiple international markets including Canada, EU, Australia, Brazil, and others. The company offers flexible licensing options (unlimited or per-case) to accommodate diverse institutional needs and serves radiology departments, cardiac imaging centers, and medical institutions globally.

Medi-Dose, Inc. is a pharmaceutical packaging and hospital supply distributor specializing in unit-dose packaging systems, liquid packaging solutions, and specialized medical consumables. Based in Ivyland, Pennsylvania, the company manufactures and distributes a broad range of products for pharmacy operations, nursing units, compounding centers, operating rooms, and specialized clinical settings including ophthalmic, maternity, and laboratory applications. Core offerings include the proprietary Medi-Dose System for unit-dose packaging, Steri-Dropper sterile dropper bottles, TampAlerT tamper-evident liquid packaging, ENFit-compliant products for enteral feeding, identification bands, safety-labeled bags for hazardous drugs (USP <800> compliant), cleanroom supplies, compounding equipment, and pharmacy auxiliary labeling systems. The company also provides MILT 4 pharmacy management software and serves hospitals, healthcare systems, and long-term care facilities with both branded and custom solutions for medication safety, infection control, and operational efficiency.

LymphaTech is a healthcare technology company specializing in validated 3D digital measurement solutions for accurate assessment of human geometry. The platform uses proprietary algorithms to measure volume and circumference of limbs with 99% accuracy compared to water displacement and tape measure methods. LymphaTech serves physical therapists, oncology clinics, compression garment manufacturers, and patients globally. The company offers three integrated solutions: a clinical iPad-based measurement system for frequent in-clinic assessments that reduces measurement time and enables longitudinal tracking; a compression garment fitting module that streamlines sizing and ordering while reducing garment remakes by 33%; and a Bluetooth tape measure with mobile app for at-home self-measurement that connects patients across the care continuum. Validated through external clinical research and adopted by NAPBC-accredited cancer centers and American Cancer Society recommended practices, LymphaTech enables clinicians to focus more on treatment delivery while improving patient engagement and compliance through simplified, standardized measurement workflows.

Centese is a medical technology company specializing in intelligent digital solutions for post-operative surgical drainage in cardiothoracic surgery. Founded in 2015 and based in Omaha, Nebraska, Centese develops FDA-cleared systems that enhance patient safety and clinical decision-making following cardiac and thoracic procedures. The company's flagship product, Thoraguard, is an automated chest tube management system that addresses critical challenges in post-operative recovery, including drainage complications, extended hospital stays, and labor-intensive nursing workflows. Thoraguard delivers real-time monitoring of drainage volume and air leak rates with 24-hour trend analysis, features the first and only automated clog clearance system for chest tubes, and provides digital alerts for unexpected disruptions. The system is designed as a compact, all-in-one platform for both cardiac and thoracic surgical populations. Centese has treated nearly 15,000 patients and is expanding across U.S. hospitals with plans to enter the European market.

Emerald Resources Healthcare is a distributor and service provider of specialized medical equipment for long-term care, hospitals, assisted living, and group homes across New York State, Pennsylvania, and New England. With over 30 years of industry experience, the company supplies fall prevention systems, patient lifting and transfer equipment, positioning and seating solutions, patient bathing systems, wandering resident alert systems using active RFID technology, infant protection systems, secure access control, and wireless nurse call systems. Emerald Resources distinguishes itself through local service support with live customer representatives and on-site technicians providing rapid response to equipment needs and maintenance.

Semler Scientific is a medical technology company specializing in early detection and management of vascular diseases, particularly peripheral arterial disease (PAD). Founded in 2007, the company develops point-of-care diagnostic devices and digital health platforms for cardiovascular assessment. QuantaFlo, its flagship product, is an FDA-cleared non-invasive test measuring arterial blood flow in extremities, enabling rapid diagnosis of PAD in both symptomatic and asymptomatic patients. The company also provides complementary solutions including SemlerShield (data security), SemlerVault (data management), SemlerAnalytics (clinical analytics), SemlerSimulation (provider training), and SemlerHub (cloud-based diagnostic platform). Semler Scientific serves healthcare providers seeking portable, evidence-based tools for vascular disease screening and monitoring, addressing the significant clinical and economic burden of PAD, which affects approximately 1 in 5 people over age 60 and costs the U.S. healthcare system over $216 billion annually.

Tenovi is a healthcare IoT platform specializing in remote patient monitoring (RPM) and remote therapeutic monitoring (RTM). The company operates a plug-and-play Cellular Gateway that aggregates data from 60+ FDA-cleared medical devices, including blood pressure monitors, pulse oximeters, scales, glucose meters, temperature monitors, peak flow meters, smart pillboxes, and activity trackers. Tenovi's proprietary technology captures comprehensive patient health data including vitals and medication adherence, automatically transmitting data via cellular connectivity (multi-carrier SIM with Wi-Fi fallback) to a cloud-based clinician software portal accessible through a single API. The platform integrates seamlessly with electronic health records (EHRs) and supports workflow automation for scalable monitoring across diverse healthcare settings. All device integrations are completed by Tenovi engineers in the USA. With SOC 2 compliance and a commitment to accuracy, cellular coverage, device selection, and quality, Tenovi serves healthcare organizations delivering value-based care to patients with chronic conditions. The company was founded in 2020 and is headquartered in Portsmouth, New Hampshire.